BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DRD2
,
Angiogenesis
,
Lung cancer
,
Hippocampus
,
Laryngoscope
,
Ciprofibrate
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DNA-binding protein inhibitor
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thyroid gland
Endometrium
Urethra
Prostate gland
Pericardium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Klinefelter's syndrome, XXY
Alpha-1-antitrypsin deficiency
Disorder of digestive system
Hypoalphalipoproteinemia
Tinea pedis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
ascorbate-2-phosphate
Ultrasound Radiation
VER 52296
saikosaponin
lac dye
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SMURF1
SAR1B
HMGN2
F2RL2
TOPBP1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Embryonic stem cells treated with bone morphogenetic protein-2
Ovarian cancer SK-OV-3 cells treated with dorsomorphin and/or BMP2
Human glioma cells treated with TGF-beta or LY2109761
Human skin fibroblasts treated with ascorbic acid 2-phosphate and ascorbic acid
Skeletal muscle myoblast L6 cells in an insulin treatment time course study
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for DNA-binding protein inhibitor
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine R…
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcino…
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Remov…
Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With Cancer
BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associate…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ